Jian Huang1, Zi-Kang Xie, Rong-Bin Lu, Zheng-Fu Xie. 1. Department of Geriatrics and Gerontology, First Affiliated Hospital, Guangxi Medical University, Nanning, People's Republic of China.
Abstract
BACKGROUND: Dysregulated levels of interleukin-1 (IL-1) were observed in patients with multiple sclerosis (MS). Previous studies have provided conflicting evidence implicating the IL-1 gene polymorphisms in MS risk. METHODS: A meta-analysis of 16 case-control studies involving 3,482 cases and 3,528 controls was conducted to evaluate this association. RESULTS: No association was found between the IL-1α -889 (rs1800587), IL-1α +4,845 (rs17561), IL-1β -511 (rs16944), IL-1β +3,953 (rs1143634), IL-1ra variable number tandem repeat (VNTR) polymorphisms and MS risk. However, in subgroup analyses for the IL-1ra VNTR polymorphism, we found that individuals carrying the 2 allele had a 32 % increased risk for bout-onset MS (relapsing remitting and secondary progressive MS) when compared to the LL homozygotes (OR = 1.32, 95 % CI = 1.06-1.66, P (z) = 0.014). CONCLUSION: Common variants in the IL-1 region are not associated with MS risk but our data suggest that the IL-1ra VNTR polymorphism might be associated with bout-onset MS subtype.
BACKGROUND: Dysregulated levels of interleukin-1 (IL-1) were observed in patients with multiple sclerosis (MS). Previous studies have provided conflicting evidence implicating the IL-1 gene polymorphisms in MS risk. METHODS: A meta-analysis of 16 case-control studies involving 3,482 cases and 3,528 controls was conducted to evaluate this association. RESULTS: No association was found between the IL-1α -889 (rs1800587), IL-1α +4,845 (rs17561), IL-1β -511 (rs16944), IL-1β +3,953 (rs1143634), IL-1ra variable number tandem repeat (VNTR) polymorphisms and MS risk. However, in subgroup analyses for the IL-1ra VNTR polymorphism, we found that individuals carrying the 2 allele had a 32 % increased risk for bout-onset MS (relapsing remitting and secondary progressive MS) when compared to the LL homozygotes (OR = 1.32, 95 % CI = 1.06-1.66, P (z) = 0.014). CONCLUSION: Common variants in the IL-1 region are not associated with MS risk but our data suggest that the IL-1ra VNTR polymorphism might be associated with bout-onset MS subtype.
Authors: C Ferri; F L Sciacca; L E Grimaldi; F Veglia; G Magnani; G Santuccio; G Comi; N Canal; L M Grimaldi Journal: J Neurol Neurosurg Psychiatry Date: 2000-10 Impact factor: 10.154
Authors: I Borzani; M R Tola; L Caniatti; A Collins; G De Santis; D Luiselli; E Mamolini; C Scapoli Journal: Eur J Neurol Date: 2010-02-23 Impact factor: 6.089
Authors: H M Schrijver; J B Crusius; B M Uitdehaag; M A García González; P J Kostense; C H Polman; A S Peña Journal: Neurology Date: 1999-02 Impact factor: 9.910
Authors: C L A Mann; M B Davies; V L Stevenson; S M Leary; M D Boggild; C Ko Ko; P W Jones; A A Fryer; R C Strange; A J Thompson; C P Hawkins Journal: J Neuroimmunol Date: 2002-08 Impact factor: 3.478
Authors: Danielle Burger; Nicolas Molnarfi; Martin S Weber; Karim J Brandt; Mahdia Benkhoucha; Lyssia Gruaz; Michel Chofflon; Scott S Zamvil; Patrice H Lalive Journal: Proc Natl Acad Sci U S A Date: 2009-03-02 Impact factor: 11.205
Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422